Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Patients often present with mild to moderate symptoms, and epithelial cell proliferation is observed via endoscopy, which may be accompanied by colonic swelling
Both medications share similar side effectsmainly nausea, vomiting, and diarrheathough retatrutide shows slightly higher rates of gastrointestinal issues in early studies
In Proc
Patients should seek urgent medical attention if they experience: Severe or persistent abdominal pain (possible pancreatitis or gallbladder complication) Signs of dehydration (dizziness, reduced urine output) due to vomiting or diarrhoea Symptoms of hypoglycaemia (shakiness, sweating, confusion) or hyperglycaemia (excessive thirst, frequent urination) Severe headache or visual disturbance (possible raised intracranial pressure) Signs of an allergic reaction (rash, swelling, difficulty breathing) Regular monitoring should include fasting glucose, HbA1c, IGF-1, lipid panels, liver function, and renal function
Categorisation of Nominated Substances: Because the evaluation process is extensive and ongoing, the FDA categorises "nominated" substances that have not yet reached a final decision
